Robert C. Newton

Preliminary results from a phase 1/2 study of INCB024360 combined with ipilimumab (ipi) in patients (pts) with melanoma.

G. Gibney, P. Scherle, O. Hamid, 2014 .

Pharmacodynamic assessment of INCB024360, an inhibitor of indoleamine 2,3-dioxygenase 1 (IDO1), in advanced cancer patients.

P. O'dwyer, P. Scherle, T. Gajewski, 2012 .